竞争性内源RNA在原发性肝癌中的研究进展

摘要/Abstract

摘要：竞争性内源RNA(ceRNA)转录本可通过与微小RNA（miRNA）竞争性结合相同的 miRNA应答元件(MRE)，从而解除或减轻miRNA对靶基因的抑制作用。近期研究表明，许多基因可作为ceRNA，通过竞争性结合相同的致瘤性或抑瘤性基因，在肝癌发生发展中起促进或抑制肿瘤生成的作用。

何晓琴,徐细明. 竞争性内源RNA在原发性肝癌中的研究进展[J]. 国际肿瘤学杂志, 2017, 44(3): 231-234.

He Xiaoqin, Xu Ximing. Research progress of the competing endogenous RNA in primary hepatocellular carcinoma[J]. Journal of International Oncology, 2017, 44(3): 231-234.

［1］ Casane D, Fumey J, Laurenti P. ENCODE apophenia or a panglossian analysis of the human genome［J］. Med Sci (Paris), 2015, 31(6/7): 680-686. DOI: 10.1051/medsci/20153106023. ［2］ Veneziano D, Di Bella S, Nigita G, et al. Noncoding RNA: current deep sequencing data analysis approaches and challenges［J］. Hum Mutat, 2016, 37（12）： 1283-1298. DOI: 10.1002/humu.23066. ［3］ Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition［J］. Nature, 2014, 505(7483): 344-352. DOI: 10.1038/nature12986. ［4］ Zhang Y, Xu Y, Feng L, et al. Comprehensive characterization of lncRNAmRNA related ceRNA network across 12 major cancers［J］. Oncotarget, 2016, 7（39）： 64148-64167. DOI: 10.18632/oncotarget.11637. ［5］ Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR3313p in gastric cancer［J］. Mol Cancer, 2014, 13(1): 92. DOI: 10.1186/14764598 1392. ［6］ Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015［J ］. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338. ［7］ Yang C, Wu D, Gao L, et al. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives［J］. Oncotarget, 2016, 7(12): 13479-13490. DOI: 10.18632/oncotarget.7266. ［8］ Cao C, Sun J, Zhang D, et al. The long intergenic noncoding RNA UFC1, a target of microRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of βcatenin in HCC cells［J］. Gastroenterology, 2015, 148(2): 415-426.e18. DOI: 10.1053/j.gastro.2014.10.012. ［9］ Yoo S, Kim HH, Kim P, et al. A HuDZBP1 ribonucleoprotein complex localizes GAP43 mRNA into axons through its 3′ untranslated region AUrich regulatory element［J］. J Neurochem, 2013, 126(6): 792-804. DOI: 10.1111/jnc.12266. ［10］ An Y, Furber KL, Ji S. Pseudogenes regulate parental gene expression via ceRNA network［J］. J Cell Mol Med, 2017, 21（1）： 185-192. DOI: 10.1111/jcmm.12952. ［11］ Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy［J］. Nat Rev Genet, 2016, 17(5): 272-283. DOI: 10.1038/nrg.2016.20. ［12］ Kluiver J, SlezakProchazka I, SmigielskaCzepiel K, et al. Generation of miRNA sponge constructs［J］. Methods, 2012, 58(2): 113-117. DOI: 10.1016/j.ymeth.2012.07.019. ［13］ Tay FC, Lim JK, Zhu H, et al. Using artificial microRNA sponges to achieve microRNA lossoffunction in cancer cells［J］. Adv Drug Deliv Rev, 2015, 81(81): 117-127. DOI: 10.1016/j.addr.2014.05.010. ［14］ Giza DE, Vasilescu C, Calin GA. MicroRNAs and ceRNAs: therapeutic implications of RNA networks［J］. Expert Opin Biol Ther, 2014, 14(9): 1285 -1293. DOI: 10.1517/14712598.2014.920812. ［15］ Karreth FA, Pandolfi PP. ceRNA crosstalk in cancer: when cebling rivalries go awry［J］. Cancer Discov, 2013, 3(10): 1113-1121. DOI: 10.1158/21598290.CD130202. ［16］ Dong P, Xiong Y, Watari H, et al. MiR137 and miR34a directly target Snail and inhibit EMT, invasion and sphereforming ability of ovarian cancer cells［J］. J Exp Clin Cancer Res, 2016, 35(1): 132. DOI: 10.1186/s130460160415y. ［17］ Dang Y, Luo D, Rong M, et al. Underexpression of miR34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting cMET［J］. PLoS One, 2013, 8(4): e61054. DOI: 10.1371/journal.pone.0061054. ［18］ ArriagaCanon C, FonsecaGuzmán Y, ValdesQuezada C, et al. A long noncoding RNA promotes full activation of adult gene expression in the chicken αglobin domain［J］. Epigenetics, 2014, 9(1): 173-181. DOI: 10.4161/epi.27030. ［19］ Gutschner T, Diederichs S. The hallmarks of cancer: a long noncoding RNA point of view［J］. RNA Biol, 2012, 9(6): 703-719. DOI: 10.4161/rna.20481. ［20］ Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let7 microRNAs［J］. Mol Cell, 2013, 52(1): 101-112. DOI: 10.1016/j.molcel.2013.08.027. ［21］ Wang F, Yuan JH, Wang SB, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem celllike property of hepatocellular carcinoma cells by stabilizing NOP2［J］. Hepatology, 2014, 60(4): 1278-1290. DOI: 10.1002/hep.27239. ［22］ Li SP, Xu HX, Yu Y, et al. LncRNA HULC enhances epithelialmesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR200a3p/ZEB1 signaling pathway［J ］. Oncotarget, 2016, 7（27）： 42431-42446. DOI: 10.18632/oncotarget.9883. ［23］ Deng L, Yang SB, Xu FF, et al. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let7 sponge［J］. J Exp Clin Cancer Res, 2015, 34: 18. DOI: 10.1186/s1304601501367. ［24］ Fang L, Du WW, Yang X, et al. Versican 3′untranslated region (3′ UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity［J］. FASEB J, 2013, 27(3): 907-919. DOI: 10.1096/fj.12220905. ［25］ Zhao L, Li F, Taylor EW. Can tobacco use promote HCVinduced miR122 hijacking and hepatocarcinogenesis?［J］. Med Hypotheses, 2013, 80(2): 131-133. DOI: 10.1016/j.mehy.2012.11.009. ［26］ Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency［J］. Nature, 2013, 495(7441): 333-338. DOI: 10.1038/nature11928. ［27］ Shang X, Li G, Liu H, et al. Comprehensive circular RNA profiling reveals that hsa_circ_0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development［J］. Medicine (Baltimore), 2016, 95 (22): e3811. DOI: 10.1097/MD.0000000000003811. ［28］ Esposito F, De Martino M, Petti MG, et al. HMGA1 pseudogenes as candidate protooncogenic competitive endogenous RNAs［J］. Oncotarget, 2014, 5(18): 8341-8354. DOI: 10.18632/oncotarget.2202. ［29］ Cheng DL, Xiang YY, Ji LJ, et al. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives［J］. Tumour Biol, 2015, 36(2): 479-488. DOI: 10.1007/s132770153093z.

[1]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[2]	彭琴, 蔡玉婷, 王伟.KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[3]	龚艳, 陈洪雷.微RNA调控卵巢癌顺铂耐药的机制研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 186-190.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	向玉玲, 谭佳杰, 熊远果, 赵丽蓉, 黎晨, 张洪.脱水淫羊藿素对肝癌细胞增殖、迁移和凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(9): 513-519.
[6]	全祯豪, 徐飞鹏, 黄哲, 黄先进, 陈日红, 孙开裕, 胡旭, 林琳.沉默lncRNA FTX通过miR-22-3p/NLRP3炎症体通路抑制胃癌细胞增殖[J]. 国际肿瘤学杂志, 2023, 50(4): 202-207.
[7]	李佳璇, 封颖璐.糖皮质激素受体在肝癌细胞生长中的作用机制[J]. 国际肿瘤学杂志, 2023, 50(4): 241-243.
[8]	和婷, 王希, 张惠中, 刘昕阳, 王会平, 董轲.血清TIM-3对肝癌患者诊断价值的研究[J]. 国际肿瘤学杂志, 2022, 49(9): 537-542.
[9]	周仁邦, 张仲传, 许志远, 朱勋兵.miR-219a-5p通过负调控HMGA2抑制骨肉瘤U2OS细胞增殖、侵袭和迁移[J]. 国际肿瘤学杂志, 2022, 49(4): 193-198.
[10]	金嘉会, 陈存海, 马学真.放射相关miRNA在乳腺癌放疗中的作用[J]. 国际肿瘤学杂志, 2022, 49(12): 735-738.
[11]	井文君, 赵文文, 冯青青, 赵文飞, 赵丽丽, 张雪, 魏红梅.miR-34家族用于胃癌治疗的分子基础及临床前景[J]. 国际肿瘤学杂志, 2022, 49(11): 681-686.
[12]	张玉敏, 赵现伟, 何前进, 陈杰能.超声造影联合血清CXCL8、CXCR2在原发性肝癌经导管动脉化疗栓塞术后疗效评估中的价值分析[J]. 国际肿瘤学杂志, 2022, 49(10): 592-596.
[13]	狄伟华, 赵雪梅.DNA损伤修复在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(10): 635-638.
[14]	罗丽云, 赖灿辉, 梁仁佩, 杨爱武, 林志敏.晚期胃癌中miR-524-5p与SOX9表达的相关性及其对化疗疗效和预后的影响[J]. 国际肿瘤学杂志, 2022, 49(1): 45-50.
[15]	杜佳航, 陈栋, 陈耀庭.三氧化二砷抗肝癌机制及其在肝癌治疗中的研究[J]. 国际肿瘤学杂志, 2021, 48(9): 572-.

竞争性内源RNA在原发性肝癌中的研究进展

Research progress of the competing endogenous RNA in primary hepatocellular carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价